Sublingual Clonidine for Hypertensive Urgencies

Clinical Context and Indications

Sublingual clonidine is most appropriately used for hypertensive urgencies (severe hypertension >159/109 mmHg without target organ damage) rather than true hypertensive emergencies, according to the American Heart Association 1, 2
The American College of Cardiology recommends sublingual clonidine as a second-line option when immediate-release nifedipine is unavailable or contraindicated, due to its slower onset of action (1-2 hours vs. 30-60 minutes for nifedipine) 1, 2
Clonidine is particularly useful in hypertensive emergencies induced by catecholamine excess, including pheochromocytoma, monoamine oxidase inhibitor interactions, cocaine toxicity, amphetamine overdose, or clonidine withdrawal, as stated by the American Society of Hypertension 3

The initial dose of sublingual clonidine is 0.1-0.2 mg, followed by 0.05-0.1 mg hourly until blood pressure goal is achieved or maximum total dose of 0.7-0.8 mg is reached, with a target reduction of at least 20/10 mmHg, ideally toward 140/90 mmHg, as recommended by the American Heart Association 1, 2

The American College of Cardiology advises against using clonidine in patients with heart failure, as it is associated with increased mortality, and to avoid its use in second- or third-degree heart block or bradycardia, with monitoring for heart rate <50 bpm 2, 3, 5
Clonidine is contraindicated in reactive airway disease or COPD, and its use should be cautious in cerebrovascular disease, due to the risk of cerebral infarction, as warned by the American Academy of Neurology 3

The American Heart Association emphasizes the importance of never abruptly discontinuing clonidine, as it can cause life-threatening rebound hypertensive crisis within 24-36 hours, and recommends mandatory tapering over at least 2-4 days (preferably 7-10 days) when discontinuing, with the initiation of alternative antihypertensive agents at the beginning of the taper 2

Clonidine is not a first-line agent for chronic hypertension management and should be reserved as a last-line option for resistant hypertension, according to the American College of Cardiology, and is considered only after failure of ACE inhibitors/ARBs, calcium channel blockers, thiazide diuretics, and typically spironolactone 4